Brief: Biopharma Veteran Ivor Macleod Joins Scynexis As Chief Financial Officer
25/10/2022 15:39
Oct 25 (Reuters) - SCYNEXIS Inc SCYX.O :
* BIOPHARMA VETERAN IVOR MACLEOD JOINS SCYNEXIS AS CHIEF
FINANCIAL
OFFICER
* SCYNEXIS INC- MACLEOD REPLACES LARRY HOFFMAN, WHO SERVED
AS
INTERIM CFO SINCE LATE 2021
Source text for Eikon: ID:nGNX2Zz5yH
Further company coverage: SCYX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Scynexis
See all newsBrief: Scynexis Announces Phase 1 Study Results For Scy-770, A Novel, Highly Selective, Oral Direct Ampk Activator For The Treatment Of Autosomal Dominant Polycystic Kidney Disease
Brief: Scynexis Announces Appointment Of Sanjay Subramanian As Chief Financial Officer
Scynexis Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Scynexis Q2 swings to profit on warrant adjustment; advances drug studies
Scynexis Inc Expected To Post A Loss Of 51 Cents A Share: Earnings Preview